Back to Trades
Grant4
Quanterix Corp
QTRX
Total Value
$332.0K
Company Information
- Company Name
- Quanterix Corp
- Ticker Symbol
- QTRX
- CIK
- 0001503274
Insider Information
- Name
- LAI GOLDMAN MYLA
- Role
- Insider
- Location
- BILLERICA, MA
Filing Details
- Filing Date
- Jul 10, 2025
- Transaction Date
- Jul 8, 2025
- Accession Number
- 0001562180-25-005380
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2025 | Common Stock | 2,940 | — | Grant/Award | — |
| Jul 8, 2025 | Common Stock | 24,464 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2025 | Derivative | 50,758 | $6.54 | Grant/Award | $332.0K |
Footnotes
- (F1)Received in exchange for 20,000 shares of Akoya Biosciences, Inc. ("Akoya") common stock in connection with the acquisition of Akoya by Quanterix on July 8, 2025. Dr. Lai-Goldman received: (a) 0.1470 of a share of Quanterix common stock and (b) $0.37 in cash, for each share of Akoya common stock. The closing price of the Quanterix common stock on July 8, 2025 was $6.54 per share. The closing price of the Akoya common stock on July 7, 2025 was $1.29 per share.
- (F2)Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to one-third of the shares on each of July 8, 2026, July 8, 2027 and July 8, 2028.
- (F3)Includes 24,464 restricted stock units.
- (F4)The option vests as to one-third of the shares on July 8, 2026, and the remaining two-thirds of the shares vest monthly thereafter over two years in 24 successive equal installments.